Associate Director
United Therapeutics Corporation
Associate Director
United Therapeutics Corporation
Biotech company develops PAH therapies
California, US residentsclick here.
The job details are as follows:
Who We Are
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).
The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
Who You Are
We are looking for an Associate Director, Global PV Product Complaint Management & Oversight to lead and elevate global Product Complaint Safety governance structure across devices, drugs, combination products, and biologics at a local US and global level at all product life cycles. This position provides direction to the team and vendors with respect to PC Handling/business practices for efficiency, quality, and compliance impacts.
The ideal candidate is a confident, collaborative PV and product complaint leader who can turn complex requirements into practical solutions that protect patients and strengthen compliance. This role ensures that operational aspects of the safety data collected and processed and assessed as product complaints are managed with rigorous global standards in proper documentation, evaluation processes, and decisions to support the overall global safety surveillance program and proper management of benefit/risk of UTC products in accordance with EU MDR requirements, combination reporting requirements (21 CFR 820 and 211), IMDRF requirements, ISO 13485 (quality management systems), ISO 14971 (risk management), IEC 62304 (medical device software), and ISO 10993 (biological evaluation).
Minimum Requirements
Preferred Qualifications
Job Location
This position will be located at our Durham, NC office with a hybrid schedule of 3 days in office and the option to work 2 days each week from home. In office requirements could change based on business needs.
At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.
Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.
Biotech company develops PAH therapies
United Therapeutics develops medicines for pulmonary arterial hypertension and other rare diseases, and pursues organ manufacturing through its Xenotransplantation efforts. Its drugs are given as oral tablets, intravenous infusions, or inhaled therapies to open damaged lung vessels and support heart function, while its organ programs aim to create bioengineered organs from donor animals to reduce rejection. The company differentiates itself by pairing a pharmaceutical portfolio with regenerative medicine and organ manufacturing, and by operating as a public-benefit corporation with sustainable facilities. Its goal is to end the organ transplant shortage by supplying transplantable organs while improving patient outcomes through better drug delivery and regenerative medicine.
Explore more opportunities at United Therapeutics Corporation